Directory

>

Sean Nolan

avatar

Sean Nolan

Chief Executive Officer | Taysha Gene Therapies

Chicago, Illinois, United States

View contact details (it's free)

Sean Nolan

Summary

Sean P. Nolan is an accomplished leader in the biopharmaceutical industry, currently serving as the Chairman and CEO of Taysha Gene Therapies, where he focuses on developing innovative gene therapies for rare CNS diseases. With a robust history of leadership roles, including his previous position as President and CEO of AveXis, he played a pivotal role in the development of the groundbreaking gene therapy Zolgensma. His extensive experience spans various companies and positions, showcasing his expertise in business strategy, clinical trials, and commercialization. Sean's commitment to advancing healthcare is evident through his involvement on multiple boards, including Affinia Therapeutics and Encoded Therapeutics. He holds a B.A. in Biology from John Carroll University, reflecting his strong academic foundation in life sciences. Beyond his professional achievements, Sean is a dedicated family man, raising four children with his wife, Beth. His career is marked by a dedication to improving patient outcomes and driving innovation in the pharmaceutical sector.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Sean Nolan

Work Experience

company logo

Chief Executive Officer at

Taysha Gene Therapies

December 2022 - Present

company logo

Chairman of the Board of Directors at

Taysha Gene Therapies

March 2020 - Present

💼

President and Chief Executive Officer at

AVEXIS, s.r.o.

June 2015 - May 2018

💼

Chief Business Officer at

INTERMUNE TRUST

February 2013 - June 2015

company logo

Chief Commercial Officer at

Reata Pharmaceuticals Global, Inc.

August 2011 - December 2012

company logo

President of Lundbeck Inc. (US Affiliate of Lundbeck, Formerly Ovation Pharmaceuticals) at

Lundbeck

December 2009 - November 2010

company logo

Chief Commercial Officer/Integration Leader at

Lundbeck

March 2009 - December 2009

company logo

VP, Product Development and Global Project Management at

Lundbeck

February 2008 - March 2009

company logo

VP, CNS Business Unit at

Lundbeck

January 2006 - February 2008

company logo

VP, Marketing and Sales Operations at

Lundbeck

September 2004 - December 2005

company logo

Senior Director, Sales Operations at

Solvay Pharma Inc

July 2003 - September 2004

company logo

Director of Sales, Anti-Infectives at

Solvay Pharma Inc

July 2001 - July 2003

company logo

Director of Sales, Neuroscience at

Solvay Pharma Inc

December 1999 - July 2001

company logo

Regional Manager, Long Term Care at

Solvay Pharma Inc

July 1999 - December 1999

company logo

Senior Product Manager, Neuroscience at

Solvay Pharma Inc

May 1996 - January 1999

company logo

District Sales Manager, Neuroscience at

Solvay Pharma Inc

January 1996 - May 1997

company logo

Associate Marketing Manager, Cardiovascular at

Solvay Pharma Inc

January 1995 - January 1996

company logo

Sales Training Manager, Anti-Infectives at

Solvay Pharma Inc

September 1993 - December 1994

company logo

Sales Representative, Anti-Infectives at

Solvay Pharma Inc

May 1991 - September 1993

Logos provided by Logo.dev

Sean Nolan

Education

John Carroll University, B.S.

January 1986 - January 1990

Frequently Asked Questions about Sean Nolan

What is Sean Nolan email address?

Sean Nolan's primary email address is ******@tayshagtx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Sean Nolan work for?

Sean Nolan is a Chief Executive Officer at Taysha Gene Therapies, a company specializing in Offices of health practitioner.

Where Sean Nolan graduated from?

Sean Nolan holds a degree in Biology from John Carroll University.

How can I directly contact Sean Nolan?

To contact Sean Nolan directly, you can use the email address ******@tayshagtx.com. Complete contact information is available upon registration with Muraena.

Who is Sean Nolan?

Sean P. Nolan is an accomplished leader in the biopharmaceutical industry, currently serving as the Chairman and CEO of Taysha Gene Therapies, where he focuses on developing innovative gene therapies for rare CNS diseases. With a robust history of leadership roles, including his previous position as President and CEO of AveXis, he played a pivotal role in the development of the groundbreaking gene therapy Zolgensma. His extensive experience spans various companies and positions, showcasing his expertise in business strategy, clinical trials, and commercialization. Sean's commitment to advancing healthcare is evident through his involvement on multiple boards, including Affinia Therapeutics and Encoded Therapeutics. He holds a B.A. in Biology from John Carroll University, reflecting his strong academic foundation in life sciences. Beyond his professional achievements, Sean is a dedicated family man, raising four children with his wife, Beth. His career is marked by a dedication to improving patient outcomes and driving innovation in the pharmaceutical sector.

Sean`s contact details

mail

******@tayshagtx.com

**********@att.net

******@stiefel.com

******@avexis.com

Colleagues

avatar
Patrick Nolan

Director, Business Development & R&D Chief of Staff

avatar
Frederick Porter

Chief Technical Officer

avatar
Kome Okposo

Medical Affairs

avatar
Leigh Fuller

Executive Director, Quality

Kamran Alam

Chief Financial Officer

avatar
Chelsea Karbocus

Executive Director, Head of Patient Advocacy

avatar
Brad Martin

Head of Market Access and Trade

avatar
Emily Mcginnis

Chief Patient and External Affairs Officer

avatar
Emily Mcginnis

Chief Patient Officer and Head of Government Affairs

View Contact details (it's free)
Request Profile Removal